tech²ART, a Danish-based private company, through it’s innovation technology strives to improve the outcome of assisted reproduction technology, the embryonic stem cell and cell culture technology at large. Our latest clinical trial proves tech²ART’s ability. The incuART, is the only advanced incubator platform that can maintain its designed environment enabling a real control of cells during incubation. The recent clinical evaluation verifies that the technology is “highly accurate and precise, both within run and between run”… Stability was evaluated during 3 and 4 days incubation of two different IVF media brands. As we all know, the culture environment.